TranS1 Inc. to Participate in the Lazard Capital Markets 4rd Annual Medical Technology Snowbird Event


WILMINGTON, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Joe Slattery, Executive Vice President and Chief Financial Officer, will participate in the LCM 4rd Annual Medical Technology Snowbird Event on Thursday, March 1, 2012 at the Snowbird Ski and Summer Resort in Snowbird, UT.

The conference format consists of a full day of one-on-one meetings. The conference will not be webcast. Institutional investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and multilevel lumbar fusion, the VEO lateral access and interbody fusion system and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion.  TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.



            

Contact Data